Hot BioTech Stocks To Watch Today

Hottest Biotech StocksI’m a bit of an addict when it comes to BioTech stocks. The strong movement we see on any given day is just exciting. With that said, here’s a list of the BioTech stocks that I’ve been watching today. I hope you enjoy!

Amarin Corporation plc (ADR) (NASDAQ: AMRN) Stocks Are Blowing Up Today!

Amarin Corporation plc (ADR) (NASDAQ: AMRN) stocks have been the talk of the town recently. The company was recently upgraded by a highly respectable analyst in a big way. As a result, the stock gained more than 20% per day on both Thursday and Friday of last week. On Monday and Tuesday, we started to see some correction as the growth proved to be too much too fast. However, the stock is back on the uptrend today. Amarin Corporation plc (ADR) (NASDAQ: AMRN) is currently (12:14) trading for $2.72 per share after gaining 14.88% so far today.

Outlook – Amarin Corporation plc (ADR) (NASDAQ: AMRN) is a great company that’s slated for long term growth. Although we’ll see strong uptrends followed by strong downtrends in the short term, the growth should level out; leading to profits for the longs.

MannKind Corporation (NASDAQ: MNKD) Stocks Are Falling As Investors Worry About Debt

MannKind Corporation (NASDAQ: MNKD) stocks have had a hard time in the market throughout the past month. Following an unfounded downgrade by Goldman Sachs, the stock fell dramatically. Since then, the trends have been moving in the downward motion and the stock has struggled to change tides. Unfortunately, the losses continue today as investors start to worry about the looming $100 million debt payment. Currently (12:20), MannKind Corporation (NASDAQ: MNKD) is trading for $5.35 per share after a loss of 1.83% so far today.

Outlook – I still think that MannKind Corporation (NASDAQ: MNKD) is a great company that will most likely grow over the long term. While the major debt repayment may be an issue now, I have strong confidence that the company will make it through just fine and come out profiting on the other end.

Gilead Sciences, Inc. (NASDAQ: GILD) Stocks Are Falling Following A Policy Shift

Medication is expensive, we all know that! However, there is a major policy shift taking place that will most likely hinder Gilead profits. The policy change is the result of backlash from an $84,000 treatment. Congress and consumers argue that the cost of the treatment is far too much. So, we’re starting to see a policy change in pricing for prescription drugs, and it can be a major pain to Gilead Sciences, Inc. (NASDAQ: GILD). Currently (12:27), Gilead Sciences, Inc. (NASDAQ: GILD) is trading at $99.26 per share after losing 1.17% so far today.

Outlook – When it comes to Gilead Sciences, Inc. (NASDAQ: GILD), I think we’re going to see good things in the long run. While a major policy change could hinder growth in the short term, the company has proven that it has the ability to overcome obstacles.

Herbalife Ltd. (NYSE: HLF) Stocks Are Soaring On Case Dismissal

Recently, Herbalife Ltd. (NYSE: HLF) was taken to court by an investor that claimed he lost a good majority of his investment due to fraud on Herbalife’s part. The case came as the result of claims by Bill Ackman that Herbalife Ltd. (NYSE: HLF) is a pyramid scheme. Yesterday, the courts ruled that Herbalife Ltd. (NYSE: HLF) did nothing wrong and the company’s stock is up today in a big way because of it. Currently (12:31), Herbalife Ltd. (NYSE: HLF) is trading for $37.59 per share after gaining 9.18% so far today.

Outlook – Herbalife Ltd. (NYSE: HLF) is a great company that provides something that most consumers need. With that said, I think we’re going to see long term growth out of this one despite what Bill Ackman has to say.

Genetic Technologies Limited (ADR) (NASDAQ: GENE) Stocks Are Still Suffering From Dilution

Recently, Genetic Technologies Limited (ADR) (NASDAQ: GENE) announced that it had raised a rather hefty sum of money. In order to do so, the company issued new shares. As we know happens when new stocks are issued, Genetic Technologies Limited (ADR) (NASDAQ: GENE) stocks have suffered losses as the result of dilution. Unfortunately, it seems as though the downtrends are continuing. Currently (12:39), Genetic Technologies Limited (ADR) (NASDAQ: GENE) is trading at $4.04 per share after falling 5.83% so far today.

Outlook – In the long run, I’m expecting great things from Genetic Technologies Limited (ADR) (NASDAQ: GENE). While dilution is a bit of a kicker at the moment, the company has the ability to grow in the long run!

Biocept Inc (NASDAQ: BIOC) Stocks Fall As Shorts Continue Causing Pain

Biocept Inc (NASDAQ: BIOC) stocks have been down recently as an increase in shorts following the Zachs rating takes their toll on the stock. Unfortunately, the downtrends are continuing today. Currently (12:49), Biocept Inc (NASDAQ: BIOC) is trading at $2.32 per share after losing 2.93% so far today.

Outlook – Sadly, I don’t have anything positive to say about this stock. After the dramatic falls we’ve seen recently, I’d definitely stay away from this one.

AEterna Zentaris Inc. (NASDAQ: AEZS) Stocks Continue To Climb On Earnings

AEterna Zentaris Inc. (NASDAQ: AEZS) recently released it’s Q4 earning report. The report blew analyst expectations away; beating earnings per share predictions by $0.22! As a result, the stock has started to skyrocket. Currently (12:52), AEterna Zentaris Inc. (NASDAQ: AEZS) is trading for $0.56 per share after gaining 5.97% so far today. Outlook – If you follow my writing, you know that I love positive earnings. In this particular case, the stock blew earnings away and we’re expecting great things from the next report. So, it’s long all the way for me!

Cytori Therapeutics Inc (NASDAQ: CYTX) Stocks Continue Falling

I always find it interesting when the value of a stock climbs following a poor earnings report. That’s exactly what we saw from Cytori Therapeutics Inc (NASDAQ: CYTX). However, in my opinion, the climb just didn’t make sense. Well, it seems as though investors are finally starting to realize that poor earnings aren’t a reason to invest; and Cytori Therapeutics Inc (NASDAQ: CYTX) stocks are falling hard. Currently (12:56), Cytori Therapeutics Inc (NASDAQ: CYTX) is trading for $1.24 per share after losing 6.06% so far today. Outlook – I’m no psychic, but I don’t see good things in the future of Cytori Therapeutics Inc (NASDAQ: CYTX) stock. The reality is that the company is currently operating at a loss. Generally, investors like profits!

Orexigen Therapeutics Inc (NASDAQ: OREX) Stocks Seem To Be Correcting Today

Yesterday, Orexigen Therapeutics Inc (NASDAQ: OREX) stocks skyrocketed; gaining 7.88% from the previous close. Unfortunately, the momentum doesn’t seem to be going in the same direction today. However, it shouldn’t be a major concern as we tend to see corrections following major increases. Outlook – Orexigen Therapeutics Inc (NASDAQ: OREX) is a great company. Sure, they may have gotten on the FDA’s bad side recently, but overall, I see growth in their future.

Inovio Pharmaceuticals Inc (NASDAQ: INO) Stocks Seem To Be Correcting As Well

Inovio Pharmaceuticals Inc (NASDAQ: INO) stocks were on a strong uptrend Monday and Tuesday this week. Unfortunately, the trend seems to have stopped, but is there reason to be concerned? In my opinion, the answer is no. I think what we’re seeing is the realization that the stock grew too much, too fast; and the market is performing a healthy correction. Currently (1:04), Inovio Pharmaceuticals Inc (NASDAQ: INO) is trading for $8.43 per share after losing 1.52% so far today. Outlook – While I think that there’s a possibility that Inovio Pharmaceuticals Inc (NASDAQ: INO) will start on the uptrend again in the near future, I also think it’s important to remember that the company is operating at a loss. All in all, I’d still stay away from this one.

What Do You Think?

Do you have an opinion on any of the BioTech stocks mentioned here? If so, we’d love to see it in the comments below! If you know of any other fast moving BioTech stocks, please include those as well!

Image Credit

Add Comment